The risk of cardiovascular disease following breast cancer by Framingham risk score

Breast Cancer Research and Treatment
Sofie A M GernaatPetra H M Peeters

Abstract

This study evaluates the risk of cardiovascular disease (CVD) following breast cancer, accounting for baseline CVD risk. Within the EPIC-NL (Dutch part of the European Prospective Investigation into Nutrition and Cancer) cohort, 1103 women were diagnosed with breast cancer. For every breast cancer patient, 3-4 women without breast cancer (n = 4328) were selected matched for age, year, and time since cohort enrollment. Based on CVD risk factors at cohort enrollment, 10-year risk of CVD was calculated and categorized: low (< 10%), intermediate (10-20%), high (> 20%). Cox proportional hazard models assessed the risk of CVD events (hospitalization or mortality) and CVD mortality of women with versus without breast cancer, adjusted for baseline CVD risk. After median follow-up of 5 and 6 years, 92 (8.3%) and 325 (7.5%) CVD events occurred in women with and without breast cancer, respectively. In the low CVD risk group, women with breast cancer had 1.44 (95% CI 1.00-2.06) times higher risk of CVD events than women without breast cancer. In the intermediate and high CVD risk categories, risk of CVD events was similar in women with and without breast cancer. Overall, women with breast cancer had 1.77 (95% CI 1.10-2.86) times higher ris...Continue Reading

References

Apr 1, 1992·Journal of Epidemiology and Community Health·R M HeringsG Nap
Jan 1, 1997·International Journal of Epidemiology·M C OckéD Kromhout
Mar 3, 2004·Nature Reviews. Cancer·Sheila Bingham, Elio Riboli
Sep 2, 2004·Journal of the National Cancer Institute·Catherine SchairerSusan S Devesa
Feb 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Greger NilssonCarl Blomqvist
Oct 28, 2005·The New England Journal of Medicine·Donald A BerryUNKNOWN Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John J DoyleDawn L Hershman
Feb 1, 2006·International Journal of Radiation Oncology, Biology, Physics·Maartje J HooningFlora E van Leeuwen
Nov 8, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maartje J HooningFlora E van Leeuwen
Mar 8, 2007·Journal of the National Cancer Institute·Maartje J HooningFlora E van Leeuwen
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary C PinderSharon H Giordano
Nov 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emer O HanrahanVicente Valero
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Feb 14, 2008·Journal of the National Cancer Institute·Judith-Anne W ChapmanPaul E Goss
Apr 16, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Hazel B NicholsPolly A Newcomb
Jun 2, 2009·International Journal of Epidemiology·Joline W J BeulensH Bas Bueno-de-Mesquita
Jun 13, 2009·Journal of the American College of Cardiology·Edward T H Yeh, Courtney L Bickford
May 19, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M RiihimäkiK Hemminki
Jul 15, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Paul McGaleMarianne Ewertz
Sep 14, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edoardo ColzaniKamila Czene
Nov 18, 2011·European Journal of Epidemiology·UNKNOWN InterAct ConsortiumNick Wareham
Aug 2, 2013·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Sujethra Vasu, W Gregory Hundley
Oct 16, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mariana Chavez-MacGregorSharon H Giordano
Jun 16, 2014·Breast Cancer Research and Treatment·Claudia OmariniStephen R D Johnston
Aug 30, 2014·Journal of the American College of Cardiology·Pimprapa Vejpongsa, Edward T H Yeh
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Dec 6, 2014·Research in Cardiovascular Medicine·Behnam DalfardiTouraj Asvadi-Kermani
Sep 29, 2015·Epidemiology·Patrick T BradshawMarilie D Gammon
Oct 27, 2015·JAMA : the Journal of the American Medical Association·Evan R MyersGillian D Sanders
Dec 26, 2015·International Journal of Epidemiology·Connie W Tsao, Ramachandran S Vasan
Mar 16, 2016·Circulation·Ryan J KoeneSuma H Konety
Sep 21, 2016·Cancer Causes & Control : CCC·Marjorie L McCulloughMia M Gaudet
Oct 11, 2016·World Journal of Cardiology·Jason R CuomoNeal L Weintraub
Nov 11, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N G ZaorskyJ E Meyer

❮ Previous
Next ❯

Citations

Nov 18, 2019·Breast Cancer Research and Treatment·Kirsten A NyropHyman B Muss
Apr 3, 2019·Journal of Translational Medicine·Stine Overvad FredslundAnders Bonde Jensen
May 26, 2020·Radiation Oncology·Aurélie GaaschStefanie Corradini
Feb 22, 2021·European Journal of Internal Medicine·Seamus P WheltonOmar Dzaye
Apr 3, 2021·Breast Cancer Research and Treatment·Arnethea L SuttonVanessa B Sheppard
Mar 27, 2021·British Journal of Clinical Pharmacology·Stine Overvad FredslundBritt Elmedal Laursen
Apr 20, 2021·JACC. CardioOncology·Emily S LauJennifer E Ho
Jul 13, 2021·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Yvonne KoopHester Vermeulen
Sep 24, 2019·JACC. CardioOncology·Christine E Simmons
Oct 9, 2021·International Journal of Radiation Oncology, Biology, Physics·Sanne G M van VelzenIvana Išgum

❮ Previous
Next ❯

Software Mentioned

SAS
SPSS
MORGEN

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Related Papers

European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology
Sarah BosJ W J Beulens
© 2022 Meta ULC. All rights reserved